WilmerHale is pleased to announce that Richard Hoffman will rejoin its Boston office as a partner in the Transactional Department and Corporate and Life Sciences Groups. He has more than 25 years of corporate, legal and business development experience in the life sciences industry. Mr. Hoffman has significant expertise in establishing new companies and advising existing companies on corporate, financial and business development strategies.
“We are delighted to welcome Richard back to WilmerHale,” said Susan Murley, Co-Managing Partner of WilmerHale. “Together with our existing lawyers focused in the life sciences area, his unique experience as a lawyer, consultant and entrepreneur in this industry will further strengthen our ability to provide cutting edge advice to biotechnology, medical device and pharmaceutical company clients.”
Mr. Hoffman began his career as an associate and, later, as a junior partner at Hale and Dorr LLP. He worked in the corporate group from 1987 through 1994, specializing in the representation of biotechnology and medical device companies in venture capital financings, public offerings, collaborative research arrangements and strategic alliances. Since 1994, Mr. Hoffman dedicated himself to pursuing entrepreneurial endeavors, serving as a business development executive at several companies and a legal advisor and business consultant to biotech companies and venture capital firms.
“I am eager to be a part of WilmerHale’s renowned life sciences practice,” said Mr. Hoffman. “The firm recognizes my years of experience within the industry and, in turn, I am excited to rejoin WilmerHale’s extensive team of life sciences lawyers. I look forward to collaborating with my new colleagues to provide superior service and counsel to our clients.”
The life sciences industry is a significant part of WilmerHale’s practice, with more than 100 of its lawyers devoting a significant portion of their practice to this industry. The firm has represented life sciences clients in boardrooms and courtrooms across the United States and Europe for four decades. As a result of its successful representation of public and private companies, investment banks and venture capitalists in all aspects of the life sciences industry, the firm is ranked among the top six firms in the nation for life sciences work by Chambers USA 2012 and among the leading practices in the world by Chambers Global 2012 in its Life Sciences Global-wide category.
Mr. Hoffman received a BA in Biochemical Sciences from Harvard College, a JD from Columbia University School of Law and an MBA from The Wharton School at the University of Pennsylvania. He was a Research Fellow in the Department of Biochemistry at the University of Lausanne. Mr. Hoffman is admitted to the Massachusetts, Maryland and District of Columbia Bars.
